2027年先進治療大会

Advanced Therapies Congress 2027

Europe's largest commercial cell and gene therapy conference and exhibition, bringing together 3,000+ global executives, 300+ speakers, and 75+ biotech start-ups. The event covers the entire value chain of Advanced Therapy Medicinal Products (ATMPs), featuring pharma, biotech, researchers, clinicians, HTAs, payers, and regulators.

Main Content Tracks and Categories

• Ensuring Clinical Success:Regulatory challenges, reimbursement frameworks, market access, cross-border healthcare, and outcome-based agreements.
• Cell Therapy Frontiers:Autologous vs. allogeneic approaches, solid tumours, combination therapy, CAR-T, NK, Gamma-Delta cells, and patient stratification.
• Stem Cells:Regenerative medicine, MSCs vs. iPSCs, and cord blood advancements.
• Next-Generation Gene Therapy:Transitioning from rare to common diseases, immunogenicity, orphan drugs, and novel delivery systems.
• Manufacturing & Automation:Closed systems, scaling up, continuous manufacturing, cost reduction, and in-house vs. outsourcing.
• Immunotherapy for Solid Tumours:AI in oncology and precision medicine.
• Logistics & Supply Chain:Cold chain distribution, point-of-care delivery, and clinical-to-commercial transitions.
• Emerging Innovations:Academic research, cutting-edge technologies, safety ethics, biomarkers, and precision vaccinology.
• Start-Ups & Adoption:Company presentations, investor perspectives, patient pathways, and accessibility.

---

参展或展位注册

---

场馆地图和周边酒店

ロンドン - ExCeL ロンドン, イングランド, イギリス